1. Home
  2. NTWK vs PLUR Comparison

NTWK vs PLUR Comparison

Compare NTWK & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSol Technologies Inc.

NTWK

NetSol Technologies Inc.

HOLD

Current Price

$2.95

Market Cap

35.5M

Sector

Technology

ML Signal

HOLD

Logo Pluri Inc.

PLUR

Pluri Inc.

N/A

Current Price

$2.99

Market Cap

31.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NTWK
PLUR
Founded
1997
2001
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.5M
31.5M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
NTWK
PLUR
Price
$2.95
$2.99
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
42.7K
49.1K
Earning Date
02-12-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.04
N/A
Revenue
$66,501,654.00
$1,326,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
N/A
$293.97
P/E Ratio
$74.92
N/A
Revenue Growth
7.70
121.74
52 Week Low
$2.14
$2.82
52 Week High
$5.75
$7.13

Technical Indicators

Market Signals
Indicator
NTWK
PLUR
Relative Strength Index (RSI) 39.60 40.10
Support Level $2.96 $2.90
Resistance Level $3.13 $3.42
Average True Range (ATR) 0.15 0.25
MACD 0.03 -0.00
Stochastic Oscillator 0.00 18.89

Price Performance

Historical Comparison
NTWK
PLUR

About NTWK NetSol Technologies Inc.

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: